Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:57 pm Sale | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | CITADEL ADVISORS LLC | 2,458,958 6.5% | -293,237 (-10.65%) | View |
| 2024-02-14 4:00 pm Purchase | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | TANG CAPITAL PARTNERS LP | 3,652,244 9.6% | 919,994 (+33.67%) | View |
| 2024-02-13 5:00 pm Sale | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | Vivo Capital VIII LLC | 2,073,005 5.5% | -200,000 (-8.80%) | View |
| 2024-02-12 9:41 pm Unchanged | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.1% | 0 (Unchanged) | View |
| 2023-04-20 4:13 pm Purchase | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | TANG CAPITAL PARTNERS LP | 2,732,250 7.2% | 2,732,250 (New Position) | View |
| 2023-02-14 08:02 am Sale | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | CITADEL ADVISORS LLC | 2,752,195 7.3% | -60,254 (-2.14%) | View |
| 2023-02-13 12:36 pm Sale | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | SUVRETTA CAPITAL MANAGEMENT LLC | 0 0% | -2,230,250 (Position Closed) | View |
| 2023-01-04 4:20 pm Sale | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Novo Holdings A/S | 0 0% | -2,534,465 (Position Closed) | View |
| 2022-12-28 2:51 pm Sale | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Novo Holdings A/S | 2,534,465 6.7% | -1,169,526 (-31.57%) | View |
| 2022-09-30 4:48 pm Unchanged | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Novo Holdings A/S | 3,703,991 9.8% | 0 (Unchanged) | View |
| 2022-07-15 4:01 pm Sale | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Novo Holdings A/S | 3,703,991 9.8% | -800,000 (-17.76%) | View |
| 2022-05-16 4:31 pm Sale | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | RA CAPITAL MANAGEMENT L.P. | 0 0% | -2,378,325 (Position Closed) | View |
| 2022-02-14 06:12 am Sale | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | CITADEL ADVISORS LLC | 2,812,449 7.5% | -129,558 (-4.40%) | View |
| 2021-11-29 4:39 pm Purchase | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | SUVRETTA CAPITAL MANAGEMENT LLC | 2,230,250 6% | 2,230,250 (New Position) | View |
| 2021-11-22 4:03 pm Unchanged | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Novo Holdings A/S | 4,503,991 12% | 0 (Unchanged) | View |
| 2021-08-13 5:02 pm Purchase | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Pivotal bioVenture Partners Fund I L.P. | 3,058,419 8.4% | 1,166,952 (+61.70%) | View |
| 2021-04-07 4:30 pm Purchase | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | RA CAPITAL MANAGEMENT L.P. | 2,378,325 6.5% | 2,378,325 (New Position) | View |
| 2021-02-19 4:03 pm Purchase | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | CITADEL ADVISORS LLC | 2,942,007 8.1% | 2,942,007 (New Position) | View |
| 2021-02-18 4:50 pm Purchase | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | Vivo Capital VIII LLC | 2,273,005 6.6% | 2,273,005 (New Position) | View |
| 2021-02-17 4:56 pm Purchase | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Pivotal bioVenture Partners Fund I L.P. | 1,891,467 5.5% | 1,891,467 (New Position) | View |